IGFBP3-mediated activation of the EGFR and IGF1R has been suggested previously in breast cancer epithelial cells, in which treatment of cells with IGFBP3 resulted in ligand-stimulated EGFR and IGF1R activation and subsequent downstream DNA synthesis [29]. Here, EGFR is linked to breast carcinoma.